Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive Ballard

Showing results (271-280 of 480) with videos related to

Pageof 48
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)|September 1, 2020
Whole transcriptome in silico screening implicates cardiovascular and infectious disease in the mechanism of action underlying atypical antipsychotic side effectsYasaman Malekizadeh, Gareth Williams, Mark Kelson, et al.
International Journal of Geriatric Psychiatry|January 28, 2024
The relationship between playing musical instruments and cognitive trajectories: Analysis from a UK ageing cohortGaia Vetere, Gareth Williams, Clive Ballard, et al.
Dementia and Geriatric Cognitive Disorders|February 22, 2011
A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's diseaseAlistair Burns, Elaine Perry, Clive Holmes, et al.
Aging & Mental Health|July 14, 2015
FITS into practice: translating research into practice in reducing the use of anti-psychotic medication for people with dementia living in care homesDawn J Brooker, Isabelle Latham, Simon C Evans, et al.
Plos Medicine|April 4, 2008
A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial)Clive Ballard, Marisa Margallo Lana, Megan Theodoulou, et al.
Journal of the American Medical Directors Association|May 18, 2016
Apathy and Its Response to Antipsychotic Review and Nonpharmacological Interventions in People With Dementia Living in Nursing Homes: WHELD, a Factorial Cluster Randomized Controlled TrialAnto P Rajkumar, Clive Ballard, Jane Fossey, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 14, 2019
Enrichment factors for clinical trials in mild-to-moderate Alzheimer's diseaseClive Ballard, Alireza Atri, Neli Boneva, et al.
European Journal of Psychotraumatology|January 4, 2024
Is lifetime traumatic brain injury a risk factor for mild cognitive impairment in veterans compared to non-veterans?Rebecca Akhanemhe, Sharon A M Stevelink, Anne Corbett, et al.
International Review of Psychiatry (Abingdon, England)|September 10, 2024
The mind and motion: exploring the interplay between physical activity and Mild Behavioral Impairment in dementia-free older adultsDinithi Mudalige, Dylan X Guan, Clive Ballard, et al.
Neurobiology of Aging|August 29, 2006
Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivorsMichael J Firbank, Emma J Burton, Robert Barber, et al.
Pageof 48

Showing results (271-280 of 480) with videos related to

Sort By:
Pageof 48
Alzheimer'S & Dementia (New York, N. Y.)|September 1, 2020
Whole transcriptome in silico screening implicates cardiovascular and infectious disease in the mechanism of action underlying atypical antipsychotic side effectsYasaman Malekizadeh, Gareth Williams, Mark Kelson, et al.
International Journal of Geriatric Psychiatry|January 28, 2024
The relationship between playing musical instruments and cognitive trajectories: Analysis from a UK ageing cohortGaia Vetere, Gareth Williams, Clive Ballard, et al.
Dementia and Geriatric Cognitive Disorders|February 22, 2011
A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's diseaseAlistair Burns, Elaine Perry, Clive Holmes, et al.
Aging & Mental Health|July 14, 2015
FITS into practice: translating research into practice in reducing the use of anti-psychotic medication for people with dementia living in care homesDawn J Brooker, Isabelle Latham, Simon C Evans, et al.
Plos Medicine|April 4, 2008
A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial)Clive Ballard, Marisa Margallo Lana, Megan Theodoulou, et al.
Journal of the American Medical Directors Association|May 18, 2016
Apathy and Its Response to Antipsychotic Review and Nonpharmacological Interventions in People With Dementia Living in Nursing Homes: WHELD, a Factorial Cluster Randomized Controlled TrialAnto P Rajkumar, Clive Ballard, Jane Fossey, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 14, 2019
Enrichment factors for clinical trials in mild-to-moderate Alzheimer's diseaseClive Ballard, Alireza Atri, Neli Boneva, et al.
European Journal of Psychotraumatology|January 4, 2024
Is lifetime traumatic brain injury a risk factor for mild cognitive impairment in veterans compared to non-veterans?Rebecca Akhanemhe, Sharon A M Stevelink, Anne Corbett, et al.
International Review of Psychiatry (Abingdon, England)|September 10, 2024
The mind and motion: exploring the interplay between physical activity and Mild Behavioral Impairment in dementia-free older adultsDinithi Mudalige, Dylan X Guan, Clive Ballard, et al.
Neurobiology of Aging|August 29, 2006
Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivorsMichael J Firbank, Emma J Burton, Robert Barber, et al.
Pageof 48